Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis

World Journal of Gastroenterology

Volumn 16, Issue 18, 2010, Pages 2252-2259

  Wang, Kai ^a,c   Yuan, Chuan Ping ^a   Wang, Wei ^a   Yang, Zhan Qing ^a   Cui, Wei ^a   Mu, Lian Zhi ^a   Yue, Zhan Peng ^a   Yin, Xiu Ling ^b   Hu, Zhong Ming ^c   Liu, Ju Xiong ^a  

^a JILIN UNIVERSITY   (China)

^b Department of Veterinary Medicine   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Immunohistochemistry; Inflammatory bowel disease; Interleukin 6; Neuroimmunomodulation; Real time transcription polymerase chain reaction

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CELLULAR DISTRIBUTION; COLITIS; COLON; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 77952616485     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i18.2252     Document Type: Article

References (39)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205
2. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-1699
3. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20: 495-549
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533
5. Rouveix B. Clinical pharmacology of cytokines. Eur Cytokine Netw 1997; 8: 291-293
6. Saadé NE, Abou Jaoude PG, Saadeh FA, Hamoui S, Safieh- Garabedian B, Kanaan SA, Atweh SF, Jabbur SJ. Fos-like immunoreactivity induced by intraplantar injection of endotoxin and its reduction by morphine. Brain Res 1997; 769: 57-65
7. Boraschi D, Cifone MG, Falk W, Flad HD, Tagliabue A, Martin MU. Cytokines in inflammation. Joint Workshop of the Deutsche Gesellschaft für Immunologie (DGfI) and the Gruppo di Cooperazione in Immunologia (GCI) Assergi (L'Aquila, Italy), February 8-11, 1998. Eur Cytokine Netw 1998; 9: 205-912
8. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117: 1162-1172
9. Haddad JJ. Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/ pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines Cell Mol Ther 2000; 6: 177-187
10. Horohov DW. Equine cytokines: past, present and future. J Equine Vet Sci 2003; 23: 331-332
11. Holloway AF, Rao S, Shannon MF. Regulation of cytokine gene transcription in the immune system. Mol Immunol 2002; 38: 567-580
12. Haddad JJ, Saadé NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 2002; 133: 1-19
13. Safieh-Garabedian B, Jalakhian RH, Saadé NE, Haddad JJ, Jabbur SJ, Kanaan SA. Thymulin reduces hyperalgesia induced by peripheral endotoxin injection in rats and mice. Brain Res 1996; 717: 179-183
14. Haddad JJ, Fahlman CS. Redox- and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine? Biochem Biophys Res Commun 2002; 297: 163-176
15. Haddad JJ. The involvement of L-gamma-glutamyl-L-cysteinyl- glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 2002; 63: 305-320
16. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998; 187: 461-468
17. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18: 428-432
18. Gross V, Andus T, Caesar I, Roth M, Schölmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992; 102: 514-519
19. Mitsuyama K, Toyonaga A, Sasaki E, Ishida O, Ikeda H, Tsuruta O, Harada K, Tateishi H, Nishiyama T, Tanikawa K. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 1995; 36: 45-49
20. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803
21. Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 1990; 186: 729-742
22. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-352
23. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182: 1281-1290
24. Pizarro TT, Arseneau KO, Bamias G, Cominelli F. Mouse models for the study of Crohn's disease. Trends Mol Med 2003; 9: 218-222
25. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20: 495-549
26. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 1992; 149: 1666-1670
27. Hill AT, Bayley DL, Campbell EJ, Hill SL, Stockley RA. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1 antitrypsin deficiency. Eur Respir J 2000; 15: 886-890
28. Carey R, Jurickova I, Ballard E, Bonkowski E, Han X, Xu H, Denson LA. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 446-457
29. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 2000; 164: 4878-4882
30. Funakoshi K, Sugimura K, Anezaki K, Bannai H, Ishizuka K, Asakura H. Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis. Digestion 1998; 59: 73-78
31. Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol 1999; 34: 66-74
32. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157: 683-694
33. Layé S, Gheusi G, Cremona S, Combe C, Kelley K, Dantzer R, Parnet P. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol 2000; 279: R93-R98
34. Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J. The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci 1998; 62: 2315-2320
35. Baier PC, May U, Scheller J, Rose-John S, Schiffelholz T. Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. Behav Brain Res 2009; 200: 192-196
36. Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002; 1592: 323-343
37. Sun Y, März P, Otten U, Ge J, Rose-John S. The effect of gp130 stimulation on glutamate-induced excitotoxicity in primary hippocampal neurons. Biochem Biophys Res Commun 2002; 295: 532-539
38. Zocchia C, Spiga G, Rabin SJ, Grekova M, Richert J, Chernyshev O, Colton C, Mocchetti I. Biological activity of interleukin- 10 in the central nervous system. Neurochem Int 1997; 30: 433-439
39. Frei K, Lins H, Fontana A. Production and function of IL-10 in the central nervous system. Schweiz Arch Neurol Psychiatr 1994; 145: 30-31